Terms: = Leukemia AND LMNA, EMD2, 4000, ENSG00000160789, LGMD1B, LDP1, PRO1, LMNC, FPLD, CDDC, HGPS, P02545, LFP, IDC, CMD1A, CDCD1, LMN1, CMT2B1, FPL AND Treatment
55 results:
1. Assessment of the
Nasr GM; Thawabieh OM; Talaat RM; Moawad M; El Hamshary MO
Front Biosci (Landmark Ed); 2024 Apr; 29(4):162. PubMed ID: 38682177
[TBL] [Abstract] [Full Text] [Related]
2. Risk Factors for treatment-Related Amenorrhea in Female Survivors of Childhood and Adolescent Cancer: 10-Year Experiences at Oncofertility Clinic in Korean Tertiary Center.
Park SJ; Choi JY; Kang HJ; Lee YJ; Lee YA; Han JY; Kim SW; Kim H; Ku SY
J Adolesc Young Adult Oncol; 2024 Feb; 13(1):162-169. PubMed ID: 38064519
[No Abstract] [Full Text] [Related]
3. Novel and replicated clinical and genetic risk factors for toxicity from high-dose methotrexate in pediatric acute lymphoblastic leukemia.
Zobeck M; Bernhardt MB; Kamdar KY; Rabin KR; Lupo PJ; Scheurer ME
Pharmacotherapy; 2023 Mar; 43(3):205-214. PubMed ID: 36764694
[TBL] [Abstract] [Full Text] [Related]
4. The Monocytic Cell Line THP-1 as a Validated and Robust Surrogate Model for Human Dendritic Cells.
Hölken JM; Teusch N
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674966
[TBL] [Abstract] [Full Text] [Related]
5. Two pediatric oncologic cases of hypereosinophilic syndrome and review of the literature.
Voeller J; DeNapoli T; Griffin TC
Cancer Rep (Hoboken); 2022 Nov; 5(11):e1710. PubMed ID: 36241191
[TBL] [Abstract] [Full Text] [Related]
6. Structure-Activity Relationship Study of Indolin-5-yl-cyclopropanamine Derivatives as Selective Lysine Specific Demethylase 1 (LSD1) Inhibitors.
Li C; Su M; Zhu W; Kan W; Ge T; Xu G; Wang S; Sheng L; Gao F; Ye Y; Wang J; Zhou Y; Li J; Liu H
J Med Chem; 2022 Mar; 65(5):4335-4349. PubMed ID: 35200034
[TBL] [Abstract] [Full Text] [Related]
7. Multiplex Screening for Interacting Compounds in Paediatric Acute Myeloid Leukaemia.
Cairns LV; Lappin KM; Mutch A; Ali A; Matchett KB; Mills KI
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576326
[TBL] [Abstract] [Full Text] [Related]
8. Arsenic compounds: The wide application and mechanisms applied in acute promyelocytic leukemia and carcinogenic toxicology.
Liu G; Song Y; Li C; Liu R; Chen Y; Yu L; Huang Q; Zhu D; Lu C; Yu X; Xiao C; Liu Y
Eur J Med Chem; 2021 Oct; 221():113519. PubMed ID: 33984805
[TBL] [Abstract] [Full Text] [Related]
9. Successful treatment of Delayed Methotrexate Clearance Using Glucarpidase Dosed on Ideal Body Weight in Obese Patients.
Krüger C; Engel N; Reinert J; Alsdorf W; Fiedler W; Dierlamm J; Bokemeyer C; Langebrake C
Pharmacotherapy; 2020 May; 40(5):479-483. PubMed ID: 32239519
[TBL] [Abstract] [Full Text] [Related]
10. treatment value of second-generation BCR-ABL1 tyrosine kinase inhibitors compared with imatinib to achieve treatment-free remission in patients with chronic myeloid leukaemia: a modelling study.
Shih YT; Cortes JE; Kantarjian HM
Lancet Haematol; 2019 Aug; 6(8):e398-e408. PubMed ID: 31208943
[TBL] [Abstract] [Full Text] [Related]
11. Simultaneous Determination of Imatinib, Dasatinib, and Nilotinib by Liquid Chromatography-Tandem Mass Spectrometry and Its Application to Therapeutic Drug Monitoring.
Wojnicz A; Colom-Fernández B; Steegmann JL; Muñoz-Calleja C; Abad-Santos F; Ruiz-Nuño A
Ther Drug Monit; 2017 Jun; 39(3):252-262. PubMed ID: 28490048
[TBL] [Abstract] [Full Text] [Related]
12. ZEB1 regulates glioma stemness through LIF repression.
Edwards LA; Li A; Berel D; Madany M; Kim NH; Liu M; Hymowitz M; Uy B; Jung R; Xu M; Black KL; Rentsendorj A; Fan X; Zhang W; Yu JS
Sci Rep; 2017 Feb; 7(1):69. PubMed ID: 28246407
[TBL] [Abstract] [Full Text] [Related]
13. HPLC-UV ASSAY OF IMATINIB IN HUMAN PLASMA OPTIMIZED FOR BIOEQUIVALENCE STUDIES.
Kaza M; Piorkowska E; Filist M; Rudzki PJ
Acta Pol Pharm; 2016 Nov; 73(6):1495-1503. PubMed ID: 29634103
[TBL] [Abstract] [Full Text] [Related]
14. Efficacy and safety of vitamin D supplementation in patients with chronic lymphocytic leukemia.
Kubeczko M; Nowara E; Spychałowicz W; Wdowiak K; Bednarek A; Karwasiecka D; Chudek J; Wojnar J
Postepy Hig Med Dosw (Online); 2016 May; 70(0):534-41. PubMed ID: 27333923
[TBL] [Abstract] [Full Text] [Related]
15. Selective Induction of Apoptosis by Azadarichta indica Leaf Extract by Targeting Oxidative Vulnerabilities in Human Cancer Cells.
Roma A; Ovadje P; Steckle M; Nicoletti L; Saleem A; Pandey S
J Pharm Pharm Sci; 2015; 18(4):729-46. PubMed ID: 26626256
[TBL] [Abstract] [Full Text] [Related]
16. DBS sampling in imatinib therapeutic drug monitoring: from method development to clinical application.
Antunes MV; Raymundo S; Wagner SC; Mattevi VS; Vieira N; Leite R; Reginato F; Capra MZ; Fogliatto L; Linden R
Bioanalysis; 2015; 7(16):2105-17. PubMed ID: 26327189
[TBL] [Abstract] [Full Text] [Related]
17. Phase II Trial of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide after Reduced-Intensity Busulfan/Fludarabine Conditioning for Hematological Malignancies.
Alousi AM; Brammer JE; Saliba RM; Andersson B; Popat U; Hosing C; Jones R; Shpall EJ; Khouri I; Qazilbash M; Nieto Y; Shah N; Ahmed S; Oran B; Al Atrash G; Ciurea S; Kebriaei P; Chen J; Rondon G; Champlin RE
Biol Blood Marrow Transplant; 2015 May; 21(5):906-12. PubMed ID: 25667989
[TBL] [Abstract] [Full Text] [Related]
18. Thyroid abnormalities in survivors of childhood cancer.
Çağlar AA; Oğuz A; Pınarlı FG; Karadeniz C; Okur A; Bideci A; Koçak Ü; Bora H
J Clin Res Pediatr Endocrinol; 2014 Sep; 6(3):144-51. PubMed ID: 25241607
[TBL] [Abstract] [Full Text] [Related]
19. Farnesyltransferase inhibitors: a comprehensive review based on quantitative structural analysis.
Moorthy NS; Sousa SF; Ramos MJ; Fernandes PA
Curr Med Chem; 2013; 20(38):4888-923. PubMed ID: 24059235
[TBL] [Abstract] [Full Text] [Related]
20. [Long-term results of HBV and HCV infection in patients with blood system diseases].
Garmaeva TTs; Kulikov SM; Mikhaĭlova EA; Gemdzhian EG; Gaponova TV; Grumbkova LO; Iaroslavtseva NG; Tupoleva TA; Somova AV; Makarik TA; Glinshchikova OA; Fevraleva IS; Sudarikov AB; Filatov FP; Savchenko VG
Ter Arkh; 2011; 83(7):17-26. PubMed ID: 21894747
[TBL] [Abstract] [Full Text] [Related]
[Next]
